医院太平间外包、天价殡葬费……这些乱象终于要被彻底整治了！国家多部门联合出手，发布医疗卫生 机构亡故患者全流程服务管理规定，明确多条"红线"。 ...

【导读】上午 A 股三大指数集体上涨，商业航天、 Sora 概念股大涨，石油天然气领跌 中国基金报记者 张舟 大家好，新的一周又开始了，基金君和你继续关注市场行情。 1 月 12 日上午， A 股三大股指集体上涨，沪指强势站上 4150 点，沪深两市 半日成交额超 2.3 万亿元，已 连续第 10 个交易日突破 2 万亿元。 截至午间收盘，沪指报 4151.14 点，涨 0.75% ，深证成指涨 1.31% ，创业板指涨 1.17% 。 AI 应用再度爆发 Sora 概念股强势走高 上午， AI 应用再度爆发， Sora 概念股强势拉升，多只概念股涨停。 个股掀 " 涨停潮 " 。其中，流金科技录得 30cm 涨停，拓尔思、易点天下、中文在线均录得 20cm 涨停，博瑞传播、国脉文化、视觉中国等录得 10cm 涨停。 | Sora概念 (文 | 盯盘 | 问财 | | --- | --- | --- | | 名称 | 分时 | 涨幅/现价 | | 流金科技 | | +29.92% | | 920021 | | 9.51 | | 拓尔思 | | +20.02% | | 300229 | | 26.44 | | ...

新华社北京1月12日电（记者李恒）根据国家卫生健康委等6部门12日公布的《医疗卫生机构亡故患者全 流程服务管理规定》，医疗卫生机构应立足主责主业，不得开展殡仪服务。 ...

Core Viewpoint - The Hong Kong stock market's healthcare sector is experiencing significant activity, particularly in brain-computer interfaces and AI healthcare, with notable gains in various stocks and the launch of a new healthcare ETF [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect healthcare sector index has seen a continuous rise, gaining over 1% and marking seven consecutive days of increases since the beginning of 2026 [1]. - Notable stock performances include: - Yimray Sunshine: 8.76% increase, current price at 8.320, market cap of 3.3 billion - Aidi Kang Holdings: 6.81% increase, current price at 5.020, market cap of 3.7 billion - MicroPort Robotics-B: 6.49% increase, current price at 26.900, market cap of 27.7 billion [1]. Group 2: ETF Launch and Characteristics - The newly launched Hong Kong Stock Connect Healthcare ETF (159137) is designed to passively track the healthcare theme index, which includes key sectors such as CXO, AI healthcare, medical devices, and innovative drugs [3]. - The healthcare theme index has demonstrated high elasticity and volatility, with a maximum increase of over 148% during the last healthcare bull market, significantly outperforming comparable indices [3]. Group 3: Recent Developments and Innovations - Recent advancements in brain-computer interfaces and AI healthcare have led to increased attention in the healthcare sector, with OpenAI launching ChatGPTHealth and Neuralink planning large-scale production of brain-computer interface devices by 2026 [4][5]. - Tsinghua University has developed an AI-driven high-throughput drug virtual screening platform, showcasing significant research progress in the field [5]. - The National Medical Products Administration in China is working on standards for medical devices utilizing brain-computer interface technology, indicating a supportive regulatory environment for innovation [5]. Group 4: Investment Opportunities - The A-share market offers investment tools such as the largest healthcare ETF (512170), which includes 12 AI healthcare and brain-computer interface concept stocks, with a combined weight of over 36% [6]. - The current price-to-earnings ratio of the CSI Healthcare Index is 35.46, indicating a favorable valuation compared to historical averages, suggesting potential investment opportunities [6].

Group 1 - The Hong Kong stock market's medical sector remains active, with brain-computer interface and AI medical concepts leading the gains, as evidenced by significant stock price increases for companies like MicroPort Robotics and Alibaba Health [1][8] - The Hong Kong Stock Connect Medical Theme Index has seen a continuous rise for seven days since the beginning of 2026, indicating strong investor interest in the sector [1][8] - The newly launched Hong Kong Stock Connect Medical ETF (Huabao, 159137) is actively trading and aims to passively track the medical theme index, reflecting the growing interest in medical investment tools [1][8] Group 2 - The Hong Kong Stock Connect Medical ETF is anchored on medical innovation, covering key sectors such as CXO, AI medical, medical devices, and innovative drugs, including popular themes like brain-computer interfaces and AI medical [3][11] - The medical theme index has shown high elasticity and volatility, with a maximum increase of over 148% during the last medical bull market, significantly outperforming comparable indices [3][11] Group 3 - Recent developments in the brain-computer interface and AI medical fields have led to increased attention in the medical sector, with notable advancements from companies like Neuralink and research achievements from Tsinghua University [5][13] - Policy initiatives, such as the National Medical Products Administration's plans for standards related to brain-computer interface medical devices, and Beijing's action plan for AI in healthcare, are expected to further stimulate the sector [5][13] Group 4 - Institutional analysis indicates that major overseas pharmaceutical companies are increasing their focus on innovative medical devices in China, suggesting a favorable market environment similar to the previous year's innovative drug sector [6][13] - The A-share medical investment tools, particularly the largest medical ETF (512170), cover a significant portion of AI medical and brain-computer interface stocks, indicating a strong investment opportunity [6][14]

Group 1 - Eddiecon Holdings (09860) saw its stock price rise over 8% in early trading, currently up 6.38% at HKD 5, with a trading volume of HKD 5.2193 million [1] - OpenAI announced the launch of ChatGPT Health, a dedicated space for health-related conversations that integrates with electronic medical records and various health applications, providing responses based on user health information and personal context [1] - Anthropic introduced a new medical service compliant with HIPAA standards for its chatbot Claude, allowing hospitals, healthcare providers, and consumers to handle protected health data, while also enhancing its product with scientific databases and biology research capabilities [1] Group 2 - Domestic AI medical applications are leading, with Ant Group's "Afu" app doubling its monthly active users to 30 million and surpassing 10 million daily inquiries, attributed to its comprehensive service from health consultation to online appointment booking and insurance payment [2] - Eddiecon Holdings launched the "Aixiao Medical" intelligent assistant for doctors, offering a one-stop service that includes testing recommendations, intelligent consultations, report interpretations, and professional Q&A, while also developing a medical AI model "Wenyi" to enhance clinical decision support and multimodal data integration capabilities [2]

数据显示，华宝基金旗下1只基金位居美年健康十大流通股东。华宝中证医疗ETF（512170）三季度减 持1512.18万股，持有股数8866.4万股，占流通股的比例为2.29%。根据测算，今日浮盈赚取约5408.5万 元。 华宝中证医疗ETF（512170）成立日期2019年5月20日，最新规模264.04亿。今年以来收益10.11%，同 类排名457/5579；近一年收益21.65%，同类排名3340/4202；成立以来收益12.09%。 1月12日，美年健康涨9.95%，截至发稿，报6.74元/股，成交1.34亿元，换手率0.51%，总市值263.82亿 元。 资料显示，美年大健康产业控股股份有限公司位于上海市静安区灵石路697号健康智谷9号楼三楼，成立 日期1991年1月22日，上市日期2005年5月18日，公司主营业务涉及健康体检、健康管理业务。主营业务 收入构成为：体检服务95.67%，其他服务4.33%。 从美年健康十大流通股东角度 责任编辑：小浪快报 截至发稿，胡洁累计任职时间13年92天，现任基金资产总规模1002.04亿元，任职期间最佳基金回报 173.62%， 任职期间最差基金回报-98.0 ...

据交易所数据显示， 迪安诊断连续两个交易日涨停，晋级2连板。该股今日于9时34分封涨停，成交额 11.97亿元，换手率9.27%。金融界App AI线索挖掘：近期 AI医疗、制药概念板块活跃度上升，1月9日 有科研团队发布AI驱动的超高通量药物虚拟筛选平台相关研究成果，相关技术突破让市场对AI在医疗 制药领域的应用价值关注度提升。 风险提示：连板股波动剧烈，注意追高风险，理性投资！（注：以 上由AI基于交易所等公开数据生成，内容不构成投资建议。） ...

Group 1 - The core viewpoint of the article highlights the strong performance of AI healthcare and pharmaceutical concepts in the early trading session, with specific companies like Dean Diagnostics and Meien Health achieving consecutive gains [1] - Companies such as Ruizhi Medicine, Innotech, Hongbo Medicine, and Weining Health also experienced upward movement in their stock prices, indicating a broader trend in the sector [1]

Core Insights - The article discusses the implementation of a medical test result mutual recognition system in Wuhan, which allows multiple hospitals to share and recognize test results, reducing the need for repeated tests and saving time and money for patients [1][2]. Group 1: Implementation and Benefits - Wuhan has added 156 new mutual recognition projects this year, bringing the total to 436, and has achieved cross-city mutual recognition of test results within the province [1]. - Patients can now avoid unnecessary repeat tests, as doctors can access recent test results from other hospitals, streamlining the diagnostic process [2]. - For example, a patient saved 72 yuan and time by not needing to repeat a kidney function test, highlighting the practical benefits of the system [1]. Group 2: System Development and Oversight - The Wuhan Municipal Health Commission has established a "Wuhan Inspection and Test Result Mutual Recognition Platform" to facilitate the sharing of test results among public medical institutions [2]. - The city’s supervisory bodies are actively monitoring the implementation of this system to ensure efficiency and address any obstacles in data sharing [2]. - The mutual recognition system currently covers routine examination and testing projects, with plans to expand its scope to further enhance patient experience [2].